# The Clinical Trial Pipeline: Auditing Eximia Research, Private Equity Site Networks, and Burbank’s Medical Testing Economy

> Burbank Ledger — Independent civic data for Burbank, California

Forensic investigative audit of Eximia Research, private equity clinical trial site networks, and Burbank's commercial bio-testing economy. Spatially joins City of Burbank GIS Public Landbase parcels (FeatureServer/17) with Los Angeles County Assessor tax rolls ($118M+ real estate footprint), audits corporate control and executive leadership (Dr. Ella Grach, VSS Capital Partners, Dr. Mitchell Nides, GHO Capital/Velocity Clinical Research, Labcorp, Quest Diagnostics, BioReference/OPKO Health), breaks down clinical trial economics ($15,000–$45,000 per completed protocol yielding 20%+ operating margins), and examines FDA regulatory compliance and Proposition 13 base-year disparities across local medical corridors.

- Site: https://burbank-ledger.pages.dev/articles/eximia-research-burbank-clinical-trials-audit/
- HTML: https://burbank-ledger.pages.dev/articles/eximia-research-burbank-clinical-trials-audit/
- License: CC BY 4.0
- Content-Signal: search=yes, ai-input=yes, ai-train=no